Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02684747 · ClinicalTrials.gov registry record · Early Phase 1

Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling

A Early Phase 1 study, sponsored by University of Utah.

Completed
Registry status
Early Phase 1
Development phase
40
Enrollment target

NCT02684747 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02684747, a Early Phase 1 study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target

Study Summary

A total of 40 subjects will be recruited for participation in this study. 20 subjects (10 males and 10 females) will be randomized to the active group (those receiving re-infusion of autologous blood) and 20 subjects (10 males and 10 females) will be randomized to the placebo group (receiving NS infusion).

Interventions

  • OTHER Autologous Transfusion
  • OTHER Control - Normal Saline (Placebo)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2016-02
Est. Completion 2018-05-05
Phase Early Phase 1

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT02684747

The ClinicalTrials.gov registry entry for NCT02684747 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Autologous Transfusion is the first listed.

NCT02684747 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02684747 about?

NCT02684747 is a clinical study titled "Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling". A total of 40 subjects will be recruited for participation in this study. 20 subjects (10 males and 10 females) will be randomized to the active group (those receiving re-infusion of autologous blood) and 20 subjects (10 males and 10 females) will be randomized to the placebo group (receiving NS inf...

What is the current status of trial NCT02684747?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2016-02. Estimated completion is 2018-05-05.

What interventions are being tested in trial NCT02684747?

The interventions under investigation include: Autologous Transfusion (OTHER), Control - Normal Saline (Placebo) (OTHER).

Who is sponsoring clinical trial NCT02684747?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.